arrow
D

David J. Tunnicliffe

the university of sydney
H指数:26
被引数:4,565

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “A methodology for determining dosing recommendations for anticancer drugs in patients with reduced kidney function”

勘误表:关于“确定肾功能减退患者抗肿瘤药物剂量推荐的方法学”

2026-10-140
OAAI
Impacts of research that are meaningful to people with chronic kidney disease and their caregivers: a workshop report

对慢性肾脏病患者及其护理人员具有意义的研究影响:一份研讨会报告

2026-07-230
PRE
Methods for living guidelines: paper 6: insights from Australian Living Evidence Collaboration's (ALEC) use of existing systematic reviews in living guideline development

活体指南的方法:论文6:澳大利亚活体证据合作组织(ALEC)在活体指南开发中使用现有系统综述的见解

2025-05-050
OAAI
A methodology for determining dosing recommendations for anticancer drugs in patients with reduced kidney function

一种用于确定肾功能减退患者抗肿瘤药物给药推荐的方法学

2025-04-011
OAAI
Patient and caregiver involvement in implementing health research in chronic kidney disease: a workshop report
2025-01-240
OAAI
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline

钠-葡萄糖cotransporter-2 (SGLT-2) 抑制剂治疗成人慢性肾脏病临床实践指南

2024-10-012
PRE
Improving Diverse and Equitable Involvement of Patients and Caregivers in Research in CKD: Report of a Better Evidence and Translation-Chronic Kidney Disease (BEAT-CKD) Workshop

改善患者和护理人员在CKD研究中的多样化和公平参与: 更好的证据和翻译-慢性肾脏病 (bete-ckd) 研讨会的报告

2024-10-011
OAAI
Consumer involvement in the development and dissemination of chronic kidney disease guidelines: a summary of a meaningful and sustainable approach developed by Caring for Australians and New ZealandeRs with kidney Impairment guidelines
2024-06-011
OAAI
Recommendations for culturally safe clinical kidney care for First Nations Australians: a guideline summary
2023-10-156
OA